Real-time enrollment status for this rsv infection clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:52 PM UTC
| NCT Number | NCT05655182 |
| Recruiting Status | Recruiting |
| Condition | RSV infection |
| Phase | PHASE1 |
| Target Enrollment | 137 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Blue Lake Biotechnology Inc. |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT05655182 is currently recruiting participants. This phase1 study for rsv infection is actively seeking new participants at 18 locations across the United States. The study is sponsored by Blue Lake Biotechnology Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05655182 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05655182 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.